Summarized by Masters of Longevity from Longevity Technology.
Two posters report preclinical metabolism and carcinogenicity findings for SIR4156.
Key Takeaways
- SIR4156 is an orally active allosteric NAMPT activator.
- Preclinical results showed reduced fat with lean-mass preservation.
- Sironax will present metabolic and carcinogenicity posters at ObesityWeek.
